Free Trial

Colgate-Palmolive (NYSE:CL) Shares Bought by Simplicity Wealth LLC

Colgate-Palmolive logo with Consumer Staples background

Simplicity Wealth LLC raised its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 393.1% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 15,064 shares of the company's stock after buying an additional 12,009 shares during the quarter. Simplicity Wealth LLC's holdings in Colgate-Palmolive were worth $1,411,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Axxcess Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 0.3% during the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company's stock valued at $3,526,000 after acquiring an additional 117 shares during the last quarter. Wescott Financial Advisory Group LLC grew its holdings in shares of Colgate-Palmolive by 3.5% during the fourth quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company's stock worth $320,000 after buying an additional 119 shares in the last quarter. Aberdeen Wealth Management LLC boosted its position in Colgate-Palmolive by 0.6% during the fourth quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock worth $1,877,000 after acquiring an additional 125 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO lifted its holdings in shares of Colgate-Palmolive by 4.0% during the 1st quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock worth $317,000 after acquiring an additional 130 shares during the period. Finally, TCW Group Inc. raised its stake in shares of Colgate-Palmolive by 0.8% in the 4th quarter. TCW Group Inc. now owns 15,932 shares of the company's stock valued at $1,448,000 after acquiring an additional 131 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Citigroup boosted their target price on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Wells Fargo & Company lifted their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a report on Wednesday, April 2nd. Barclays decreased their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. Finally, JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $102.12.

Get Our Latest Stock Report on CL

Colgate-Palmolive Stock Up 0.2%

Shares of NYSE:CL traded up $0.22 during trading on Thursday, hitting $92.33. The stock had a trading volume of 1,743,680 shares, compared to its average volume of 4,728,856. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm's fifty day moving average is $91.64 and its 200 day moving average is $91.13. The company has a market capitalization of $74.83 billion, a PE ratio of 26.23, a PEG ratio of 4.20 and a beta of 0.38. Colgate-Palmolive has a 12 month low of $85.32 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business's quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.86 EPS. Analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th were issued a dividend of $0.52 per share. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.25%. The ex-dividend date was Thursday, April 17th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Colgate-Palmolive declared that its Board of Directors has initiated a stock buyback plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Set to Crush the S&P This Summer
Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines